HARMONY will be presenting at the international conference of the Korean Society of Hematology (KSH). The virtual meeting will take place on April 1-3, 2021. The KSH is one of the highly valued members of HARMONY’s global network of collaborators.
 |
HARMONY Coordinator Jesús María Hernández Rivas (IBSAL) will present the work of the HARMONY Alliance on April 1, 2021:
#BigDataforbloodcancer | Big Data accelerate better and faster treatment for Patients with Hematologic Malignancies
The HARMONY Alliance is a European Public–Private Partnership for Big Data in Hematology that is capturing and mining Big Data on various Hematologic Malignancies. HARMONY Alliance unites more than 100 organizations such as European medical associations, hospitals, research institutes, patient organizations, pharmaceutical and IT companies. HARMONY uses Big Data analytics to accelerate the development of more effective treatments for blood cancer patients. The aim is to accelerate the development of more effective treatments. Data are stored in HARMONY’s Big Data Platform, which has already identified over 60,000 anonymized patient records, making it one of the largest databases of its kind. Leading research teams are currently using this wealth of information to answer critical questions about hematologic malignancies that cannot be addressed with other methods.
The HARMONY Alliance collaborates with prestigious hematological societies in and outside Europe, including the European Hematology Association (HARMONY Partner), the American Society of Hematology (ASH), the Latin-American MDS Group, the Korean Society of Hematology, and the Population Health Research Network from Australia.
• Join the HARMONY Alliance: watch the video below and/or contact us now >
ICKSH2021 will provide a unique opportunity to share and learn about cutting-edge developments and innovations from hematology experts from all over the globe. The program addresses benign hematologic diseases, various types of hematologic malignancies, coagulation/thrombosis related disorders and transfusion medicine through plenary lectures, as well as scientific and education sessions.
• Click here to visit the official congress website >
See what other meetings HARMONY is holding and attending by visiting our meetings page.
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
